GeneDx Holdings Corp. CEO Katherine Stueland receives $12M in 2022
GeneDx Holdings Corp. reports 2022 executive compensation
By ExecPay News
Published: April 28, 2023
GeneDx Holdings Corp. reported fiscal year 2022 executive compensation information on April 28, 2023.
In 2022, four executives at GeneDx Holdings Corp. received on average a compensation package of $5.5M, a 65% decrease compared to previous year.
Average pay of disclosed executives at GeneDx Holdings Corp.
Katherine Stueland, Chief Executive Officer, received $12M in total. 46% of Stueland's compensation, or $5.4M, was in stock awards. Stueland also received $574K in bonus, $5.4M in option awards, $454K in salary, as well as $12K in other compensation.
Kevin Feeley, Chief Financial Officer, received a compensation package of $3.7M. 44% of the compensation package, or $1.6M, was in stock awards.
Jason Ryan, Executive Chair of the Board, earned $3.2M in 2022.
Eric Schadt, Chief Executive Officer, received $3.2M in 2022, which decreases by 80% compared to 2021.
Related executives
You may also like
Source: SEC filing on April 28, 2023.